Sales of antineoplastic agents are expected to be valued at US$ 126.71 billion in 2023, with the market expected to reach a valuation of US$ 286.49 billion by the end of 2033.
The antineoplastic agents market plays a critical role in the global healthcare industry, focusing on the development and distribution of drugs that inhibit the growth and proliferation of malignant cells....
Chinese
English
Arabic
French
Spanish
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek